SERPINB13 is a prognostic biomarker for LUSC associated with an immune-inflamed tumor phenotype and modulated by immune cells
Christiane Kuempers, Karina Stein, Doerte Nitschkowski, Tobias Jagomast, Carsten Heidel, Jutta Kirfel, Daniel Droemann, Sabine Bohnet, Micheal Schweigert, Martin Reck, Till Olchers, Soenke von Weihe, Ole Ammerpohl, Torsten Goldmann
bioRxiv · Jul 16, 2026 · PreprintPathology